Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer clinical trial (NCT00088556). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to standard therapies I might receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer clinical trial (NCT00088556). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will I undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer clinical trial (NCT00088556). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer clinical trial (NCT00088556). Contact the study team or your healthcare provider for specific answers.

Question 5

What side effects should I be aware of with this combination of drugs?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer clinical trial (NCT00088556). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel requirements or logistics I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer clinical trial (NCT00088556). Contact the study team or your healthcare provider for specific answers.

What this study is about